Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
How Big Pharma Is Turning Industrial Heat Into A Strategic Asset
metallurgical plant smoke from chimneys industry drone photography Inside a pharmaceutical plant, heat is everywhere—and until recently, almost nobody was paying attention to it. Steam rising from boilers. High-temperature reactions turn raw…
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says
SHANGHAI, May 26 (Reuters) - China's booming pharmaceutical industry is not being impacted by Beijing's tightening scrutiny over deals involving sensitive technologies, the CEO of JW Therapeutics said Tuesday. Global drugmakers are…
Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions
Press release – No. 10 / 2026 Zealand Pharma to Present Data at the American Diabetes Association's 2026 Scientific Sessions Late-breaking Phase 2 ZUPREME-1 data on petrelintide to be featured as ePoster Theater presentation and poster…
Resolutions from Zealand Pharma's Extraordinary General Meeting 2026
Company announcement – No. 17 / 2026 Resolutions from Zealand Pharma's Extraordinary General Meeting 2026 Copenhagen, Denmark, May 26, 2026 - Zealand Pharma A/S ('Zealand Pharma' or the “Company”) (Nasdaq: ZEAL) (CVR-no.
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
Company announcement No. 18 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 21, 2026) Copenhagen, Denmark, May 26, 2026 – Zealand Pharma A/S ('the Company' or “Zealand Pharma”) (Nasdaq: ZEAL)…
President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?
President Trump has made it a priority to address the U.S.'s high drug prices. His administration's Most-Favored-Nation (MFN) policy, centered on the idea that Americans shouldn't have to pay more for medicines than other developed nations, seeks…
HighTower Advisors LLC Lowers Holdings in BridgeBio Pharma, Inc. $BBIO
HighTower Advisors LLC cut its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 60.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor…
BridgeBio Pharma (NASDAQ:BBIO) Cut to Market Perform at Raymond James Financial
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) was downgraded by stock analysts at Raymond James Financial from an 'outperform' rating to a 'market perform' rating in a research report issued on Tuesday. BridgeBio's Volatile Week Puts Biotech…
Nxera's President & CEO to Participate in a 'Fireside Chat' at the Jefferies New York Healthcare Conference 2026
Tokyo, Japan and Cambridge, UK, 26 May 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces its President & CEO, Chris Cargill, will participate in a ‘Fireside Chat' at the Jefferies…
Perceptic Raises $12M Seed Round To Automate Drug Discovery With AI · Digg
Original post i'm excited to unveil a $12m round for @perceptictech, operationalizing frontier ai systems to transform biopharma from @airstreet @accel elder gull and angels from ai labs @ashedwardst of fern labs (now @poolsideai) intro'd me to…
Q4 Results 26th May Highlights: EID Parry posts Q4 loss, Marksans Pharma & Astra Microwave profit up, AIA Engineering profit down, ONGC, Brainbees, JK Tyre, GIC, IRCTC, Gujarat Gas, Sumitomo Chemical to announce Q4 results
Q4 Results Today, 26th May 2026 Highlights: Find all the latest Q4 results 2026 updates of 7NR Retail, Aartech Solonics, Abhijit Trading Company, Apex Capital And Finance, Adinath Textiles, Adishakti Loha and Ispat, Aeonx Digital Technology, Aequs…
Nifty Midcap 100 hits record high as midcaps outperform weak broader markets
The Nifty Midcap 100 index closed at a record high on Tuesday, ending the session up 0.54 per cent at 62,299 after touching an intraday peak of 62,365 — its highest level ever. The index gained for a third consecutive session, defying…
Specialty chemicals, peptides, and pricing recovery: The Alkyl Amines opportunity
Perhaps anticipating this amine tailwind, the market is beginning to price it in on the stock level. Alkyl Amines Chemicals Limited, incorporated in 1979 and headquartered in Pune, is India's largest and most diversified manufacturer of aliphatic…
Ghe LLC Invests $2.37 Million in Johnson & Johnson $JNJ
Ghe LLC acquired a new position in shares of Johnson & Johnson (NYSE:JNJ - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm acquired 11,437 shares of the…
Johnson & Johnson (NYSE:JNJ) Receives Average Rating of 'Moderate Buy' from Analysts
Shares of Johnson & Johnson (NYSE:JNJ - Get Free Report) have been given an average rating of 'Moderate Buy' by the twenty-seven ratings firms that are covering the firm, Marketbeat.com reports. Seven equities research analysts have rated the stock…
Receive a Daily briefing on Pharma Industry News
Get Started